Ultragenyx Pharmaceutical, Inc. (RARE)
22.63
+0.14
(+0.62%)
USD |
NASDAQ |
Jan 20, 15:18
Ultragenyx Pharmaceutical Market Cap: 2.183B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.655B |
| Johnson & Johnson | 526.33B |
| CorMedix, Inc. | 533.40M |
| Amicus Therapeutics, Inc. | 4.417B |
| Geron Corp. | 833.05M |
Market Cap Related Metrics
| PS Ratio | 3.501 |
| Price to Book Value | 238.38 |
| Price | 22.63 |
| Earnings Yield | -26.24% |